Combination of Meds May Protect Heart Best

Published Online: Friday, July 1, 2005

Researchers report that a combination of 3 medicines—aspirin, blood pressure-lowering beta-blockers, and cholesterol-lowering statins—may more effectively improve the chances of survival for patients with heart disease than any of those taken alone. A study conducted at the University of Nottingham, England, showed that the combination resulted in an 83% reduction in deaths among these patients. The study is the first large-scale, long-term trial to find different drug combinations effective in the reduction of the risk of death in patients with heart disease. Experts have previously believed that a statin-aspirin-beta-blocker combination, along with folic acid, should be developed into a single pill that could be taken by all seniors 55 and older. Although the study suggests that such a pill could help patients with preexisting heart disease, there is no evidence to suggest that this pill should be prescribed for all seniors.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues